These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


237 related items for PubMed ID: 21214488

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Multivariate design for the evaluation of lipid and surfactant composition effect for optimisation of lipid nanoparticles.
    Martins S, Tho I, Souto E, Ferreira D, Brandl M.
    Eur J Pharm Sci; 2012 Apr 11; 45(5):613-23. PubMed ID: 22245538
    [Abstract] [Full Text] [Related]

  • 3. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure.
    Kovacevic A, Savic S, Vuleta G, Müller RH, Keck CM.
    Int J Pharm; 2011 Mar 15; 406(1-2):163-72. PubMed ID: 21219990
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)--effects of formulation parameters on physicochemical stability.
    Teeranachaideekul V, Müller RH, Junyaprasert VB.
    Int J Pharm; 2007 Aug 01; 340(1-2):198-206. PubMed ID: 17482778
    [Abstract] [Full Text] [Related]

  • 6. Influence of surfactants on the physical stability of solid lipid nanoparticle (SLN) formulations.
    Uner M, Wissing SA, Yener G, Müller RH.
    Pharmazie; 2004 Apr 01; 59(4):331-2. PubMed ID: 15125588
    [Abstract] [Full Text] [Related]

  • 7. Optimization of linalool-loaded solid lipid nanoparticles using experimental factorial design and long-term stability studies with a new centrifugal sedimentation method.
    Pereira I, Zielińska A, Ferreira NR, Silva AM, Souto EB.
    Int J Pharm; 2018 Oct 05; 549(1-2):261-270. PubMed ID: 30075252
    [Abstract] [Full Text] [Related]

  • 8. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
    Liu CH, Wu CT, Fang JY.
    Drug Dev Ind Pharm; 2010 Jul 05; 36(7):751-61. PubMed ID: 20136495
    [Abstract] [Full Text] [Related]

  • 9. Systematic approach for the formulation and optimization of atorvastatin loaded solid lipid NANOAPARTICLES using response surface methodology.
    Sarangi B, Jana U, Sahoo J, Mohanta GP, Manna PK.
    Biomed Microdevices; 2018 Jun 26; 20(3):53. PubMed ID: 29946758
    [Abstract] [Full Text] [Related]

  • 10. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles.
    Vivek K, Reddy H, Murthy RS.
    AAPS PharmSciTech; 2007 Oct 12; 8(4):E83. PubMed ID: 18181544
    [Abstract] [Full Text] [Related]

  • 11. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
    Das S, Ng WK, Tan RB.
    Eur J Pharm Sci; 2012 Aug 30; 47(1):139-51. PubMed ID: 22664358
    [Abstract] [Full Text] [Related]

  • 12. A Quality by design (QbD) approach on starch-based nanocapsules: A promising platform for topical drug delivery.
    Marto J, Gouveia LF, Gonçalves LM, Gaspar DP, Pinto P, Carvalho FA, Oliveira E, Ribeiro HM, Almeida AJ.
    Colloids Surf B Biointerfaces; 2016 Jul 01; 143():177-185. PubMed ID: 27003468
    [Abstract] [Full Text] [Related]

  • 13. Influence of preparation conditions and heat treatment on the properties of supercooled smectic cholesteryl myristate nanoparticles.
    Kuntsche J, Bunjes H.
    Eur J Pharm Biopharm; 2007 Nov 01; 67(3):612-20. PubMed ID: 17574399
    [Abstract] [Full Text] [Related]

  • 14. Differential scanning calorimetry studies on sunscreen loaded solid lipid nanoparticles prepared by the phase inversion temperature method.
    Montenegro L, Sarpietro MG, Ottimo S, Puglisi G, Castelli F.
    Int J Pharm; 2011 Aug 30; 415(1-2):301-6. PubMed ID: 21679757
    [Abstract] [Full Text] [Related]

  • 15. Topical gel of Metformin solid lipid nanoparticles: A hopeful promise as a dermal delivery system.
    Rostamkalaei SS, Akbari J, Saeedi M, Morteza-Semnani K, Nokhodchi A.
    Colloids Surf B Biointerfaces; 2019 Mar 01; 175():150-157. PubMed ID: 30530000
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Formulation of solid lipid nanoparticles (SLN): the value of different alkyl polyglucoside surfactants.
    Keck CM, Kovačević A, Müller RH, Savić S, Vuleta G, Milić J.
    Int J Pharm; 2014 Oct 20; 474(1-2):33-41. PubMed ID: 25108048
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Solid lipid nanoparticles for encapsulation of hydrophilic drugs by an organic solvent free double emulsion technique.
    Becker Peres L, Becker Peres L, de Araújo PHH, Sayer C.
    Colloids Surf B Biointerfaces; 2016 Apr 01; 140():317-323. PubMed ID: 26764112
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.